The Directive I-SMI.RL.01, “Conduct of inspections of establishments manufacturing or distributing medicinal products or collecting blood.” Version 4.0 was approved on 21 October 2024 and has thus entered into force. The purpose and scope of the document is defined as “to provide guidance on the conduct of inspection of an...